Authors' Affiliations: 1Department of Translational Hematology & Oncology Research and 2Hematologic Oncology and Blood Disorders, Taussig Cancer Institute, Cleveland Clinic; 3Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio; 4NCTT, Division of Pre-Clinical Innovations, National Center for Advancing Translational Sciences; 5Toxicology and Pharmacology Branch, Developmental Therapeutics Program, Division of Cancer Treatment and diagnosis, NCI, NIH, Bethesda, Maryland; 6College of Pharmacy, The Ohio State University, Columbus, Ohio; and 7AVANZA Laboratories, Gaithersburg, Maryland (At 2013-02-14)